Us Bancorp \De\ Arvinas, Inc. Transaction History
Us Bancorp \De\
- $77.3 Billion
- Q3 2024
A detailed history of Us Bancorp \De\ transactions in Arvinas, Inc. stock. As of the latest transaction made, Us Bancorp \De\ holds 1,675 shares of ARVN stock, worth $46,062. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,675
Previous 1,988
15.74%
Holding current value
$46,062
Previous $52,000
21.15%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ARVN
# of Institutions
221Shares Held
68.8MCall Options Held
166KPut Options Held
31.3K-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$185 Million6.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.67MShares$183 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$172 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.99MShares$110 Million0.01% of portfolio
-
Avidity Partners Management LP Dallas, TX2.99MShares$82.2 Million3.91% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $1.46B
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...